Bladder Cancer Clinical Trial

Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study

Summary

This study evaluates the effect of bladder cancer treatment on quality of life.

View Full Description

Full Description

PRIMARY OBJECTIVES:

I. To compare general and disease-specific quality of life outcomes at 6, 12, 24, and 36 months after treatment for localized bladder cancer using the PROMIS-29 and the Bladder Cancer Index (BCI) respectively.

II. To identify patient level characteristics that may influence quality of life outcomes after treatment for localized bladder cancer.

OUTLINE: This is an observational study.

Patients complete surveys and also have their medical records reviewed on study.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Have pathologically confirmed, clinically localized, bladder cancer
Be willing to complete a survey in English before starting definitive treatment (surgery or radiation);
Able to give consent.

Exclusion Criteria:

Does not meet inclusion criteria

Study is for people with:

Bladder Cancer

Estimated Enrollment:

704

Study ID:

NCT06350734

Recruitment Status:

Recruiting

Sponsor:

Mayo Clinic

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

Mayo Clinic in Arizona
Scottsdale Arizona, 85259, United States More Info
Clinical Trials Referral Office
Contact
855-776-0015
[email protected]
Mark D. Tyson, M.D., M.P.H.
Principal Investigator
Mayo Clinic in Florida
Jacksonville Florida, 32224, United States More Info
Clinical Trials Referral Office
Contact
855-776-0015
[email protected]
Paul R. Young, M.D.
Principal Investigator
Mayo Clinic in Rochester
Rochester Minnesota, 55905, United States More Info
Clinical Trials Referral Office
Contact
855-776-0015
[email protected]
Matthew T. Gettman, M.D.
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Estimated Enrollment:

704

Study ID:

NCT06350734

Recruitment Status:

Recruiting

Sponsor:


Mayo Clinic

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.